Please assess the completion status of the following clinical trial:

Trial Title: Voyager I: Patient Discharge Using the AB5000 Portable Driver System

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* The subject is an AB5000 Circulatory Support System patient (in accordance FDA-approved indications for use) who is suffering acute cardiac dysfunction and is potentially recoverable;~* The subject is male or female, age 18 years or older;~* The subject is able to ambulate unassisted;~* The subject is on stable oral anticoagulation over 7 days (INR 2-4) with no active bleeding;~* The subject is willing and able to read, understand and sign the study specific informed consent form;~* The subject agrees to comply with study protocol requirements, including all follow-up visits and completion of Qol and NIH stroke scale assessments.~Exclusion Criteria:~* The subject, pre-device implant, is qualified as a transplant candidate.~* There is an absence of a trained companion.~* There is an absence of a psycho-social support.~* The subject has an inadequate home environment, such as poor access which may hinder movements.~* The subject has experienced hypotension in last 24 hours based on two consecutive readings spaced by 8 hours with systolic blood pressures \< 90 mmHg.~* The subject requires respiratory assistance.~* The subject has an active infection (positive blood culture and/or body T ≥ 38 degrees C, and/or WBC ≥ 12K/µL).~* The subject requires tube feeding.~* The subject has any other medical condition requiring hospitalization.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).